Intensity Therapeutics, Inc.
INTS
$3.67
-$0.07-1.87%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -14.23% | -5.28% | 24.20% | -5.22% | 9.45% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -4.19% | -26.73% | 47.62% | -49.66% | 70.10% |
| Change in Net Operating Assets | 200.00% | 66.14% | -162.16% | 352.62% | 62.73% |
| Cash from Operations | -0.59% | 2.81% | -23.48% | 25.45% | 32.83% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -100.00% |
| Cash from Investing | -- | -- | -- | -- | -100.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 3.73% | 61.23% | 1,255.36% | -88.68% | 515.56% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -87.71% | 67.74% | -5,388.24% | 97.02% | -596.34% |
| Cash from Financing | 0.23% | 93.37% | 1,041.16% | -86.75% | 499.52% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 0.06% | 276.92% | 177.48% | -765.10% | 58.17% |